PT-141 dosage here means study facts, not advice
Phase 2 studies, early tests that compared amounts, followed the tanning finding. They led to the label dose; nose-spray work ended.
The label sets firm limits for one group of women
Researchers made PT-141 after a tanning study brought an unexpected sexual effect. This page reports only what the label and studies used. It is not a how-to. For women who have not passed menopause, the label names a 1.75 mg shot just below the skin. Their low desire must also cause distress. Only one use fits within 24 hours, and eight is the monthly limit [7].
The limits matter because frequent use can raise blood pressure and darken skin. The brain cells involved also help control hunger [7]. This page can't tell which dose fits your health. A licensed doctor or nurse who knows you must make that choice.
The PT-141 dosage on the label has strict caps
On the US label, the when-needed shot contains 1.75 mg and goes just below the skin. The label places it at least 45 minutes before sex. Only one use is allowed per 24 hours, and eight is the monthly cap. The rule covers women with distressing low desire who are still before menopause [7]. These facts can guide your talk with a doctor, but they aren't personal advice. The label also records a short blood-pressure rise and bars the drug for known heart disease or poorly controlled high blood pressure [7].
PT-141 dosage for women settled on one tested amount
Phase 2 means an early study that helps choose what amount to test next. This work compared 0.75, 1.25, and 1.75 mg shots in women. Researchers chose 1.75 mg for later trials [7]. The Phase 3 studies, the large tests before approval, gave 1.75 mg when needed to 1,267 women. Desire rose a little, and distress about low desire fell [3]. A 52-week study kept that amount for 684 women. The small gains held [4]. The PT-141 dosage for women in these trials was not daily.
The nose spray ended, while the shot remained
Early nose-spray studies tested roughly 7–20 mg in men with erection problems. Erections improved once the amount went above about 7 mg [1]. Researchers later dropped the spray because the amount reaching blood varied too much. A Phase 1 study, the first small safety test in people, gave women shots beneath the skin up to 2.5 mg. Some got three doses each day for 15 days [7]. That test did not become an approved use or personal advice. Other studies put the drug beneath the skin, into the nose, or into a vein [7]. Its ring shape lasts longer than a straight peptide chain.